Anette V. Finstadsveen
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Proteomic characterization of primary pancreatic fibroblasts derived from neoadjuvant chemotherapy treated versus treatment-naïve PDAC.
Journal: Journal of proteomics
Published: October 10, 2025
Global metabolomic profiling of tumor tissue and paired serum samples to identify biomarkers for response to neoadjuvant FOLFIRINOX treatment of human pancreatic cancer.
Journal: Molecular oncology
Published: August 05, 2024
Fatty acids abrogate the growth-suppressive effects induced by inhibition of cholesterol flux in pancreatic cancer cells.
Journal: Cancer cell international
Published: July 07, 2023
Pancreatic stellate cell-induced gemcitabine resistance in pancreatic cancer is associated with LDHA- and MCT4-mediated enhanced glycolysis.
Journal: Cancer cell international
Published: October 11, 2022
Neoadjuvant chemotherapy is associated with an altered metabolic profile and increased cancer stemness in patients with pancreatic ductal adenocarcinoma.
Journal: Molecular oncology
Published: July 27, 2022
Morphological Heterogeneity in Pancreatic Cancer Reflects Structural and Functional Divergence.
Journal: Cancers
Published: February 01, 2021
Differential Gemcitabine Sensitivity in Primary Human Pancreatic Cancer Cells and Paired Stellate Cells Is Driven by Heterogenous Drug Uptake and Processing.
Journal: Cancers
Published: September 26, 2020
Establishment and Characterization of Paired Primary Cultures of Human Pancreatic Cancer Cells and Stellate Cells Derived from the Same Tumor.
Journal: Cells
Published: December 16, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026